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Introduction
Phosphoryl group transfer is a widely used signalling
transfer mechanism in living organisms, ranging from
bacteria to animal cells. Phosphate transfer mecha-
nisms often comprise a part of the strategies used to
respond to different external and internal stimuli, and
protein degradation [1]. Phosphoryl-transfer reactions,
catalysed by phosphatases, remove phosphoryl groups
from macromolecules and metabolites [2]. It is esti-
mated that  35–40% of the bacterial metabolome is
composed of phosphorylated metabolites [3]. The
majority of cellular enzymes responsible for phos-
phoryl transfer belong to a rather small set of super-
families that are all evolutionary distinct, with
different structural topologies, although they are
almost exclusively restricted to phosphoryl group
transfer.
The haloalkanoate dehalogenase (HAD) superfamily
is one of the largest and most ubiquitous enzyme fami-
lies identified to date ( 48 000 sequences reported;
http://pfam.sanger.ac.uk/clan?acc=CL0137) and it is
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AraL from Bacillus subtilis is a member of the ubiquitous haloalkanoate
dehalogenase superfamily. The araL gene has been cloned, over-expressed
in Escherichia coli and its product purified to homogeneity. The enzyme
displays phosphatase activity, which is optimal at neutral pH (7.0) and
65 C. Substrate screening and kinetic analysis showed AraL to have low
specificity and catalytic activity towards several sugar phosphates, which
are metabolic intermediates of the glycolytic and pentose phosphate path-
ways. On the basis of substrate specificity and gene context within the
arabinose metabolic operon, a putative physiological role of AraL in the
detoxification of accidental accumulation of phosphorylated metabolites
has been proposed. The ability of AraL to catabolize several related sec-
ondary metabolites requires regulation at the genetic level. In the present
study, using site-directed mutagenesis, we show that the production of
AraL is regulated by a structure in the translation initiation region of the
mRNA, which most probably blocks access to the ribosome-binding site,
preventing protein synthesis. Members of haloalkanoate dehalogenase sub-
family IIA and IIB are characterized by a broad-range and overlapping
specificity anticipating the need for regulation at the genetic level. We pro-
vide evidence for the existence of a genetic regulatory mechanism control-
ling the production of AraL.
Abbreviations
HAD, haloalkanoate dehalogenase; IPTG, isopropyl thio-b-D-galactoside; pNPP, 4-nitrophenyl phosphate; pNPPase, p-nitrophenyl
phosphatase.
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highly represented in individual cells. The family was
named after the archetypal enzyme, haloacid dehalo-
genase, which was the first family member to be struc-
turally characterized [4,5]. However, it comprises a
wide range of HAD-like hydrolases, such as phospha-
tases ( 79%) and ATPases (20%), the majority of
which are involved in phosphoryl group transfer to an
active site aspartate residue [6–8]. HAD phosphatases
are involved in variety of essential biological functions,
such as primary and secondary metabolism, mainte-
nance of metabolic pools, housekeeping functions and
nutrient uptake [8]. The highly conserved structural
core of the HAD enzymes consists of a a-b domain
that adopts the topology typical of the Rossmann a ⁄b
folds, housing the catalytic site, and is distinguished
from all other Rossmanoid folds by two unique struc-
tural motifs: an almost complete a-helical turn, named
the ‘squiggle’, and a b-hairpin turn, termed the ‘flap’
[6,8,9]. The HAD superfamily can be divided into three
generic subfamilies based on the existence and location
of a cap domain involved in substrate recognition.
Subfamily I possesses a small a-helical bundle cap
between motifs I and II; subfamily II displays a cap
between the second and third motifs; and subfamily III
members present no cap domain [10]. Subfamily IIA,
based on the topology of the cap domain, can be
further divided into two subclasses: subclass IIA and
subclass IIB [10].
Presently,  2000 sequences are assigned to HAD
subfamily IIA, which covers humans and other eukary-
otes, as well as Gram-positive and Gram-negative bacte-
ria (http://www.ebi.ac.uk/interpro/IEntry?ac=IPR006357).
The Escherichia coli NagD [11] and the Bacillus subtilis
putative product AraL [12] typify this subfamily. NagD
is a nucleotide phosphatase, encoded by the nagD gene,
which is part of the N-acetylglucosamine operon (nag-
BACD). The purified enzyme hydrolyzes a number of
phosphate containing substrates, and it has a high spec-
ificity for nucleotide monophosphates and, in particu-
lar, UMP and GMP. The structure of NagD has been
determined and the occurrence of NagD in the context
of the nagBACD operon indicated its involvement in
the recycling of cell wall metabolites [13]. Although this
subfamily is widely distributed, only few members have
been characterized.
In the present study, we report the overproduction,
purification and characterization of the AraL enzyme
from B. subtilis. AraL is shown to be a phosphatase
displaying activity towards different sugar phosphate
substrates. Furthermore, we provide evidence that,
in both E. coli and B. subtilis, production of AraL is
regulated by the formation of an mRNA secondary
structure, which sequesters the ribosome-binding site
and consequently prevents translation. AraL is the first
sugar phosphatase belonging to the family of NagD-
like phosphatases to be characterized at the level of
gene regulation.
Results and Discussion
The araL gene in the context of the B. subtilis
genome and in silico analysis of AraL
The araL gene is the fourth cistron of the transcrip-
tional unit araABDLMNPQ-abfA [12]. This operon is
mainly regulated at the transcriptional level by induc-
tion in the presence of arabinose and repression by the
regulator AraR [14,15]. To date, araL is the only un-
characterized ORF present in the operon (Fig. 1). The
putative product of araL displays some similarities to
p-nitrophenyl phosphate-specific phosphatases from
the yeasts Saccharomyces cerevisiae and Schizosacchar-
omyces pombe [16,17] and other phosphatases from the
HAD superfamily, namely the NagD protein from
E. coli [13]. Although the yeast enzymes were identified
as phosphatases, no biologically relevant substrate
could be determined, and both enzymes appeared to
be dispensable for vegetative growth and sporulation.
The purified NagD hydrolyzes a number of nucleotide
and sugar phosphates.
The araL gene contains two in-frame ATG codons
in close proximity (within 6 bp; Fig. 1). The sequence
reported by Sa´-Nogueira et al. [12] assumed that the
second ATG, positioned further downstream (Fig. 1),
was the putative start codon for the araL gene because
its distance relative to the ribosome-binding site is
more similar to the mean distance (5–11 bp) observed
in Bacillus [18]. However, in numerous databases, the
upstream ATG is considered as the initiation codon
[19]. Assuming that the second ATG is correct, the
araL gene encodes a protein of 269 amino acids with a
molecular mass of 28.9 kDa.
HAD family members are identified in amino acid
alignments by four active site loops that form the
mechanistic gear for phosphoryl transfer [8]. The key
residues are an aspartate in motif I (D), a serine or
threonine motif II (S ⁄T), an arginine or lysine motif
III (R ⁄K) and an aspartate or glutamate motif IV
(D ⁄E). The NagD family members display a unique
a ⁄b cap domain that is involved in substrate recogni-
tion, located between motifs II and III [6]. This family
is universally spread; however, only a few members
have been characterized, such as NagD from E. coli
[6,11]. NagD members are divided into different sub-
families, such as the AraL subfamily [6], although all
proteins present a GDxxxxD motif IV (Fig. 2).
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Homologs of the B. subtilis AraL protein are found
in different species of Bacteria and Archea, and genes
encoding proteins with more than 50% amino acid
identity to AraL are present in Bacillus and Geobacillus
species, clustered together with genes involved in arabi-
nose catabolism. An alignment of the primary
sequence of AraL with other members of the NagD
family from different organisms, namely NagD from
E. coli (27% identity), the p-nitrophenyl phosphatases
(pNPPases) from S. cerevisiae (24% identity), Sz. pom-
be (30% identity) and Plasmodium falciparum (31%
identity), highlights the similarities and differences
(Fig. 2). AraL displays the conserved key catalytic resi-
dues that unify HAD members: the Asp at position 9
(motif I) together with Asp 218 (motif IV) binds the
cofactor Mg2+, and Ser 52 (motif II) together with
Lys 193 (motif III) binds the phosphoryl group
(Fig. 2). The cap domain is responsible for substrate
binding ⁄ specificity; thus, the uniqueness or similarity
of the amino acid sequence in this domain may deter-
mine enzyme specificity or the lack thereof [10,13,20].
Similar to the other members of the NagD family,
AraL shares two Asp residues in the cap domain
(Fig. 2). To date, the number of characterized mem-
bers of this family is scarce. In the present study, we
show that AraL possesses activity towards different
sugar phosphates. The NagD enzyme was observed to
have a nucleotide phosphohydrolase activity coupled
with a sugar phosphohydrolase activity [13]. The
P. falciparum enzyme displayed nucleotide and sugar
phosphatase activity together with an ability to
dephosphorylate the vitamin B1 precursor thiamine
monophosphate [21]. The yeast’s enzymes are p-nitro-
phenyl phosphatases; however, natural substrates were
not found [16,17]. The majority of the enzymes dis-
played in this alignment show activity to overlapping
sugar phosphates [13,21] and it is tempting to speculate
that this is related to similarities in the cap domain.
On the other hand, the variability and dissimilarity
observed in this region may determine the preference
for certain substrates (Fig. 2).
Overproduction and purification of recombinant
AraL
Full-length araL coding regions, starting at both the
first and second putative initiation ATG codons, were
separately cloned in the expression vector pET30a(+)
(Table 1), which allows the insertion of a His6-tag at
the C-terminus. The resulting plasmids, pLG5 and
pLG12 (Fig. 1), bearing the different versions of the
recombinant AraL, respectively, under the control of a
T7 promoter, were introduced into E. coli BL21(DE3)
pLysS (Table 1) for the over-expression of the recom-
binant proteins. The cells were grown in the presence
and absence of the inducer isopropyl thio-b-d-galacto-
side (IPTG), and soluble and insoluble fractions were
prepared as described in the Experimental procedures
and analyzed by SDS ⁄PAGE. In both cases, the pro-
duction of AraL was not detected, although different
methodologies for over-expression have been used (see
below).
On the basis on the alignment of the primary sequence
of AraL and NagD, we constructed a truncated version
araA          araB      araD  araL  araM     araN     araP araQ    abfA
WT 
2947.9 kb 
                                              M     R     I     M   A     S     H    D   T P V     S     P A      G     I      L     I      D        
ATCGAAAACACGGAGCAAATGCGTATTATGGCCAGTCATGATACGCCTGTGTCACCGGCTGGCATTCTGATTGAC   
M 
A A
pLG12/pLG13 
pLG11 
pLG5 
rbs 
araA          araB      araD  araM     araN     araP araQ    abfA
IQB832 
A
Fig. 1. Schematic representation of the araL genomic context in B. subtilis. White arrows pointing in the direction of transcription represent
the genes in the arabinose operon, araABDLMNPQ-abfA. The araL gene is highlighted in grey and the promoter of the transcriptional unit is
depicted by a black arrow. Depicted below the araABDLMNPQ-abfA is the in-frame deletion generated by allelic replacement DaraL. Above
is displayed the coding sequence of the 5¢-end of the araL gene. The putative ribosome-binding site, rbs, is underlined. The 5¢-end of the
araL gene present in the different constructs pLG5, pLG11, pLG12 and pLG13, is indicated by an arrow above the sequence. Mutations
introduced in the construction of pLG11, pLG13 and pLG26 are indicated below the DNA sequence and the corresponding modification in
the primary sequence of AraL is depicted above.
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of AraL in pET30a, with a small deletion at the N-ter-
minus (pLG11; Fig. 1). Production of this truncated
version of AraL was achieved in E. coli BL21 pLys(S)
DE3 cells harboring pLG12, after IPTG induction,
although the protein was obtained in the insoluble frac-
tion (data not shown). Thus, overproduction was
attempted using the auto-induction method described
by Studier [22]. In the soluble and insoluble fractions of
cells harboring pLG11, a protein of  29 kDa was
detected, which matched the predicted size for the
recombinant AraL (Fig. 3A). The protein was purified
to more than 95% homogeneity by Ni2+-nitrilotriacetic
acid agarose affinity chromatography (Fig. 3B).
Characterization of AraL
AraL phosphatase activity was measured using the syn-
thetic substrate 4-nitrophenyl phosphate (pNPP). AraL
is characterized as a neutral phosphatase with optimal
activity at pH 7 (Fig. 4). Although, at pH 8 and 9, the
activity was considerably lower than that observed at
pH 7, the values are higher than that observed at pH 6,
and no activity was measured below pH 4. The optimal
temperature was analyzed over temperatures in the
range 25–70 C. The enzyme was most active at 65 C
and, at 25 C, no activity was detected (Fig. 4). These
biophysical AraL properties fall into the range found
for other characterized phosphatases from B. subtilis:
pH 7–10.5 and 55–65 C [23–27].
HAD superfamily proteins typically employ a biva-
lent metal cation in catalysis, and phosphatases, partic-
ularly those belonging to the subclass IIA, frequently
use Mg2+ as a cofactor [3,6,8,13]. The effect of diva-
lent ions (Mg2+, Zn2+, Mn2+, Ni2+, Co2+) in AraL
activity was tested and the results obtained indicated
that catalysis absolutely requires the presence of Mg2+
(Fig. 4). The addition of EDTA to a reaction contain-
ing MgCl2, prevented AraL activity (data not shown).
------------------------------MRIMASHDTPVSPAGILIDLDGTVFRGNEL 30   ARAL_BACSU 
----------------------------------------MTIKNVICDIDGVLMHDNVA 20   NAGD_ECOLI 
-------------------MTAQQGVPIKITNKEIAQEFLDKYDTFLFDCDGVLWLGSQA 41   PNPP_YEAST 
-------------------------MAKKLSSPKEYKEFIDKFDVFLFDCDGVLWSGSKP 35   PNPP_SCHPO
MALIYSSDKKDDDIINVEKKYESFLKEWNLNKMINSKDLCLEFDVFFFDCDGVLWHGNEL 60   A5PGW7_PLAFA
                                             .: * **.: ..  
IEGAREAIKTLRRMGKKIVFLSNRGNISRAMCRKKLLGAGIE-TDVNDIVLSSSVTAAFL 89   ARAL_BACSU 
VPGAAEFLHGIMDKGLPLVLLTNYPSQTGQDLANRFATAGVD-VPDSVFYTSAMATADFL 79   NAGD_ECOLI 
LPYTLEILNLLKQLGKQLIFVTNNSTKSRLAYTKKFASFGID-VKEEQIFTSGYASAVYI 100  PNPP_YEAST 
IPGVTDTMKLLRSLGKQIIFVSNNSTKSRETYMNKINEHGIA-AKLEEIYPSAYSSATYV 94   PNPP_SCHPO 
IEGSIEVINYLLREGKKVYFITNNSTKSRASFLEKFHKLGFTNVKREHIICTAYAVTKYL 120  A5PGW7_PLAFA 
:    : :: :   *  : :::*  . :     :::   *.  .  . :  :.   : ::
KKHYRF----SKVWVLGEQGLVDELRLAGVQNASEP---------------------KEA 124   ARAL_BACSU 
RRQEGK-----KAYVVGEGALIHELYKAGFTITDVN-----------------------P 111   NAGD_ECOLI
RDFLKLQPGKDKVWVFGESGIGEELKLMGYESLGGADSRLDTPFDAAKSPFLVNGLDKDV 160   PNPP_YEAST 
KKVLKL-PADKKVFVLGEAGIEDELDRVGVAHIGGTDPSLRR--ALASEDVEKIGPDPSV 151   PNPP_SCHPO 
YDKEEYRLRKKKIYVIGEKGICDELDASNLDWLGGSNDNDKK---IILKDDLGIIVDKNI 177   A5PGW7_PLAFA 
           * :*.** .: .**   .    . 
DWLVISLHETLTYDDLNQAFQAAAG-GARIIATNKDRSFPNEDGNAIDVAGMIGAIETSA 183   ARAL_BACSU 
DFVIVGETRSYNWDMMHKAAYFVAN-GARFIATNPDTH----GRGFYPACGALCAGIEKI 166   NAGD_ECOLI 
SCVIAGLDTKVNYHRLAVTLQYLQKDSVHFVGTNVDST-FPQKGYTFPGAGSMIESLAFS 219   PNPP_YEAST 
GAVLCGMDMHVTYLKYCMAFQYLQDPNCAFLLTNQDST-FPTNGKFLPGSGAISYPLIFS 210   PNPP_SCHPO 
GAVVVGIDFNINYYKIQYAQLCINELNAEFIATNKDATGNFTSKQKWAGTGAIVSSIEAV 237   A5PGW7_PLAFA
. :: .     .:     :       .  :: ** *              * :  
QAKTELVVGKPSWLMAEAACTAMGLSAHECMIIGDSIESDIAMGKLYGMK-SALVLTGSA 242   ARAL_BACSU 
SGRKPFYVGKPSPWIIRAALNKMQAHSEETVIVGDNLRTDILAGFQAGLE-TILVLSGVS 225   NAGD_ECOLI
SNRRPSYCGKPNQNMLNSIISAFNLDRSKCCMVGDRLNTDMKFGVEGGLGGTLLVLSGIE 279   PNPP_YEAST 
TGRQPKILGKPYDEMMEAIIANVNFDRKKACFVGDRLNTDIQFAKNSNLGGSLLVLTGVS 270   PNPP_SCHPO 
SLKKPIVVGKPNVYMIENVLKDLNIHHSKVVMIGDRLETDIHFAKNCNIK-SILVSTGVT 296   A5PGW7_PLAFA 
  :     ***   : .     .     :  ::** :.:*:  .   .:  : ** :* 
KQG-----EQRLYTPDYVLDSIKDVTKLAEEGILI 272   ARAL_BACSU 
SLD---DIDSMPFRPSWIYPSVAEIDVI------- 250   NAGD_ECOLI 
TEERALKISHDYPRPKFYIDKLGDIYTLTNNEL-- 312   PNPP_YEAST 
KEEEILEKDAP-VVPDYYVESLAKLAETA------ 298   PNPP_SCHPO 
NANIYLNHNSLNIHPDYFMKSISELL--------- 322   A5PGW7_PLAFA 
.       .     *.:   .: .: 
motif I 
motif II 
cap domain 
motif III motif IV 
Fig. 2. Alignment of AraL with other pNPP-
ases members of the HAD superfamily (sub-
family IIA). The amino acid sequences of
AraL from B. subtilis (P94526), NagD
from E. coli (P0AF24), the pNPPases from
S. cerevisiae (P19881), Sz. pombe (Q00472)
and P. falciparum (A5PGW7) were aligned
using CLUSTAL W2 [41]. Similar (‘.’ and ‘:’) and
identical (‘*’) amino acids are indicated.
Gaps in the amino acid sequences inserted
to optimize alignment are indicated by a
dash (–). The motifs I, II, III and IV of the
HAD superfamily and the cap domain C2
are boxed. Open arrowheads point to the
catalytic residues in motifs I–IV. Identical
residues in all five sequences, and identical
residues in at least three sequences,
are highlighted in dark and light grey,
respectively.
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Table 1. Plasmids, oligonucleotides, and E. coli and B. subtilis strains used in the present study. Arrows indicate transformation and point
from the donor DNA to the recipient strain. The restriction sites used are underlined, as are single-nucleotide point mutations.
Plasmid, strain or
oligonucleotide Relevant construction, genotype or sequence (5¢- to 3¢) Source or Reference
Plasmids
pET30a Expression vector allowing N- or C-terminal His6 tag insertion; T7 promoter, kan Novagen
pMAD Plasmid used for allelic replacement in Gram-positive bacteria, bla, erm [37]
pAC5 Plasmid used for generation of lacZ translational fusions and integration at the
B. subtilis amyE locus, bla, cat
[39]
pLG5 araL sequence with the first putative araL start codon cloned in the pET30a vector Present study
pLG10 pMAD derivative with an in frame deletion DaraL Present study
pLG11 araL sequence with mutated GTG codon (valine at position 8) to ATG (methionine)
cloned in the pET30a vector
Present study
pLG12 araL sequence with the putative second araL start codon cloned in the pET30a
vector
Present study
pLG13 A pLG12 derivative with a mutation in the araL sequence GGC to GAC (Gly12 to Asp) Present study
pLG25 A pAC5 derivative that contains a translational fusion of araL to the lacZ gene under
the control of the arabinose operon promoter (Para)
Present study
pLG26 A pLG25 derivative with a mutation in the araL sequence ACG to AAG (Thr9 to Lys) Present study
E. coli strains
XL1 blue (recA1 endA1 gyrA96 thi-1 hsdr17 supE44 relA1 lac [F’ proAB lacIq ZDM15 Tn10
(Tetr)]
Stratagene
DH5a fhuA2 D(argF-lacZ)U169 phoA glnV44 F80 D(lacZ)M15 gyrA96 recA1 relA1 endA1
thi-1 hsdR17
Gibco-BRL
BL21(DE3)pLysS F) ompT hsdSB(rB
) mB
)) gal dcm (DE3) pLysS (CmR) [40]
B. subtilis strains
168T+ Prototroph [12]
IQB832 DaraL pLG10 fi 168T+
IQB215 DaraR::km [14]
IQB847 amyE::Para-araL’-’lacZ cat pLG25 fi 168T+
IQB848 DaraR::km amyE::Para-araL’-’lacZ cat pLG25 fi IQB215
IQB849 amyE::Para-araL’ (C fi A) -’lacZ cat pLG26 fi 168T+
IQB851 amyE:: ‘lacZ cat pAC5 fi 168T+
IQB853 amyE::Para-araL’ (T fi C and C fi G) -’lacZ cat pLG27 fi 168T+
IQB855 amyE::Para-araL’ (C fi G) -’lacZ cat pLG28 fi 168T+
IQB857 amyE::Para-araL’ (C fi A and G fi T) -’lacZ cat pLG29 fi 168T+
Oligonucleotides
ARA28 CCTATTGAATTCAAAAGCCGG
ARA253 TAACCCCAATCTAGACAGTCC
ARA358 CTGCTGTAATAATGGGTAGAAGG
ARA439 GGAATTCCATATGCGTATTATGGCCAG
ARA440 TATTTACTCGAGAATCCCCTCCTCAGC
ARA444 CGGGATCCACCGTGAAAAAGAAAGAATTGTC
ARA451 GAATTCATAAAGAAGCTTTGTCTGAAGC
ARA456 CGGCGCGTCATATGGCCAGTCATGATA
ARA457 TGATACGCATATGTCACCGGCTGGC
ARA458 CTCAGCCAATTTGGTTACATCCTTGTCCAAGTCAATCAGAATGCCAGCCGGTGCCAC
ARA459 GTGTCACCGGCTGGCATTCTGATTGACTTGGACAAGGATGTAACCAAATTGGCTGAG
ARA460 CGTGAATTCACCGAGCATGTCACCAAAGCC
ARA477 AATCAGAATGGGATCCGGTGA
ARA486 CGGCTGACATTCTGATTGACTTGGACGG
ARA487 CAATCAGAATGTCAGCCGGTGACACAGG
ARA509 CC AGT CAT GAT AAG CCT GTG TCA CCG
ARA510 CGG TGA CAC AGG CTT ATC ATG ACT GG
ARA514 TAATACGCATTTGCTC CGT GTT TTC GTC ATA AAA TAA AAC GCT TTC AAA TAC
ARA515 GTATTTGAAAGCGTTTTATTTTATGACGAA AAC ACG GAG CAA ATG CGT ATT A
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AraL is a sugar phosphatase
AraL is a phosphatase displaying activity towards the
synthetic substrate pNPP, although there is no evi-
dence that pNPPase activity is physiologically relevant.
The context of araL within the arabinose metabolic
operon araABDLMNPQ-abfA, as involved in the
transport of l-arabinose oligomers, further intracellu-
lar degradation and catabolism of l-arabinose
[12,28,29], suggests a possible role as a phosphatase
active towards sugar phosphate intermediates in l-
arabinose catabolism, such as d-xylulose 5-phosphate.
On the basis of this, as well as the observation that
many HAD members display phosphatase activities
against various intermediates of the central metabolic
pathways, glycolysis and the pentose phosphate path-
way [3], we tested AraL activity towards glucose 6-
phosphate, fructose 6-phosphate, fructose 1,6-bisphos-
phate, 3-phosphoglycerate, ribose 5-phosphate, d-xylu-
lose 5-phosphate and galactose 1-phosphate. Although,
B. subtilis does not utilize d-arabinose, the activity
towards d-arabinose 5-phosphate was also assayed. In
addition, the nucleotides AMP, ADP, ATP, pyri-
doxal 5-phosphate and thiamine monophosphate were
also screened (Table 2). Although the optimal tempera-
ture for enzyme activity is 65 C, the kinetics parame-
ters were measured at 37 C, which is the optimal
growth temperature for B. subtilis. It is noteworthy
that, under these conditions, the KM determined for
pNPP is 50 mm (Table 2) compared to 3 mm obtained
at 65 C (data not shown).
The AraL enzyme showed reactivity with d-xylu-
lose 5-phosphate, d-arabinose 5-phosphate, galactose
1-phosphate, glucose 6-phosphate, fructose 6-phos-
phate and fructose 1,6-bisphosphate (Table 2). The KM
values are high ( 30 mm) and above the range of the
known bacterial physiological concentrations. In
E. coli, the intracellular concentration of ribose 5-phos-
phate, glucose 6-phosphate, fructose 6-phosphate and
fructose 1,6-bisphosphate is in the range 0.18–6 mm [3]
and, in B. subtilis, the measured concentration of
fructose 1,6-bisphosphate when cells were grown in the
presence of different carbon sources, including arabi-
nose, varies in the range 1.8–14.1 mm [30]. However, we
cannot rule them out as feasible physiological substrates
because, under certain conditions, the intracellular
concentrations of glucose 6-phosphate, fructose
6-phosphate and fructose 1,6-bisphosphate may reach
20–50 mm, as reported for Lactococcus lactis [31]. Nev-
ertheless, the mean value of the substrate specificity
constant kcat ⁄KM is low (1 · 102 m)1Æs)1); thus, the abil-
ity of AraL to distinguish between these sugar phos-
phate substrates will be limited. The results obtained
for AraL are comparable to those obtained for other
members of HAD from subfamilies IIA and IIB,
which have in common a low substrate specificity and
catalytic efficiencies (kcat ⁄KM < 1 · 105 m)1Æs)1) and
Table 1. (Continued).
Plasmid, strain or
oligonucleotide Relevant construction, genotype or sequence (5¢- to 3¢) Source or Reference
ARA516 CAC CAC GCT CAT CGA TAA TTT CAC C
ARA549 GGC CAG TCA TGA TAG GCC TGT GTC ACC
ARA550 GGT GAC ACA GGC CTA TCA TGA CTG GCC
ARA551 GCA AAT GCC TAT TAT GGC CAG TCA TGA TAG GCC TGT GTC
ARA552 GAC ACA GGC CTA TCA TGA CTG GCC ATA ATA GGC ATT TGC
ARA553 CGG AGC AAA TGC TTA TTA TGG CCA GTC
ARA554 GAC TGG CCA TAA TAA GCA TTT GCT CCG
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Fig. 3. Overproduction and purification of recombinant AraL-His6.
(A) Analysis of the soluble (S) and insoluble (P) protein fraction
(20 lg of total protein) of induced cultures of E. coli Bl21(DE3)
pLysS harboring pET30a (control) and pLG11 (AraL-His6). (B) Analy-
sis of different fractions of purified recombinant AraL eluted with
300 mM imidazole. The proteins were separated by SDS ⁄PAGE
12.5% gels and stained with Coomassie blue. A white arrowhead
indicates AraL-His6. The size (kDa) of the broad-range molecular
mass markers (Bio-Rad Laboratories) is indicated.
AraL sugar phosphatase from B. subtilis L. M. Godinho and I. de Sa´-Nogueira
2516 FEBS Journal 278 (2011) 2511–2524 ª 2011 The Authors Journal compilation ª 2011 FEBS
lack defined boundaries of physiological substrates
[10,13]. These features are indicative of enzymes func-
tioning in secondary metabolic pathways.
Production of AraL in E. coli is subjected to
regulation
In silico DNA sequence analysis of pLG12 and pLG5
detected the possible formation, in both plasmids,
of a mRNA secondary structure, which sequesters
the ribosome-binding site. Both, hairpin structures,
display a low free energy of )17.5 kcalÆmol)1
(Fig. 5A) and )22.7 kcalÆmol)1 (data not shown),
respectively, and could impair translation that pre-
vents the production of AraL observed in these con-
structs (see above). In plasmid pLG11 carrying the
truncated version of AraL, overproduction was suc-
cessful (Fig. 3). Deletion of the 5¢-end of the araL
gene caused an increase of the free energy of the
putative mRNA secondary structure ()11.8
kcalÆmol)1; data not shown). To test the potential
involvement of the mRNA secondary structure in
the lack of production of the recombinant AraL ver-
sions constructed in plasmids pLG12 and pLG5,
site-directed mutagenesis was performed using pLG12
as template. A single-base substitution G fi A intro-
duced at the 5¢-end of the gene (Fig. 1) was designed
to increase the free energy of the mRNA secondary
structure in the resulting plasmid pLG13. This
point mutation increased the free energy from
)17.5 kcalÆmol)1 to )13.1 kcalÆmol)1 (Fig. 5A). In
addition, this modification caused the substitution of
a glycine to an aspartate at position 12 in AraL
(G12 fi D; Fig. 1); however, based on the structure
of NagD from E. coli [13], this amino acid substitu-
tion close to the N-terminus is not expected to cause
major interference in the overall protein folding. Cell
extracts of induced E. coli Bl21 pLys(S) DE3 cells
carrying pLG13 were tested for the presence of
AraL. A strong band with an estimated size of
 29 kDa was detected (Fig. 5B), strongly suggesting
that recombinant AraL is produced in E. coli when
the mRNA secondary structure is destabilized. This
observation indicates that the production of AraL is
modulated by a secondary mRNA structure placed
at the 5¢-end of the araL gene.
Fig. 4. Effect of pH, temperature and
co-factor concentration on AraL activity.
Enzyme activity was determined
using pNPP as substrate, at 65 C, pH 7,
and 15 mM MgCl2, unless stated
otherwise. The results represent the mean
of three independent experiments.
Table 2. Kinetic constants for AraL against various substrates.
Assays were performed at pH 7 and 37 C, as described in the
Experimental procedures. The results are the mean ± SD of tripli-
cates. Substrates tested for which no activity was detected were:
ATP, ADP, AMP, ribose 5-phosphate, glycerol 3-phosphate, pyri-
doxal 5-phosphate and thiamine monophosphate.
Substrate KM (mM) kcat (s
)1)
kcat ⁄ KM
(s)1ÆM)1)
D-xylulose
5-phosphate
29.14 ± 4.87 2.75 ± 0.26 0.943 · 102
Glucose
6-phosphate
24.96 ± 4.08 2.49 ± 0.26 0.998 · 102
D-Arabinose
5-phosphate
27.36 ± 1.8 2.92 ± 0.10 1.06 · 102
Fructose
6-phosphate
34.89 ± 4.51 2.817 ± 0.22 0.807 · 102
Fructose
1,6-bisphosphate
40.78 ± 11.40 1.49 ± 0.26 0.365 · 102
Galactose 1-phosphate 40.74 ± 6.03 4.28 ± 0.40 1.02 · 102
pNPP 50.00 ± 23.32 0.012 ± 0.0006 0.24
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Regulation and putative role of AraL in B. subtilis
In B. subtilis, the formation of a similar hairpin struc-
ture at the same location is possible and displays a free
energy of )21.4 kcalÆmol)1 (Fig. 6A). To determine its
role in the regulation of araL expression, a transla-
tional fusion of the 5¢-end of the araL gene to the lacZ
reporter gene from E. coli was constructed and inte-
grated into the B. subtilis chromosome, as a single
copy, at an ectopic site. The construct comprises the
araL ribosome-binding site, the initiation codon and a
fusion between codon 10 of araL and codon 7 of
E. coli lacZ. The araL¢-¢lacZ translational fusion is
under the control of the strong promoter (Para) of the
araABDLMNPQ-abfA operon (Fig. 6B). However,
expression from the araL¢-¢lacZ fusion in the presence
of arabinose (inducer) is very low, as determined by
measuring the levels of accumulated b-galactosidase
activity in strain IQB847 (Fig. 6B). By contrast, strain
IQB849 carrying a single-base substitution C fi A
introduced in the hairpin region displayed an augment
in araL¢-¢lacZ expression of  30-fold in the presence
of inducer (Fig. 6B). This point mutation increased the
free energy of the mRNA secondary structure from
)21.4 kcalÆmol)1 to )15.4 kcalÆmol)1 (6 kcalÆmol)1;
Fig. 6B). Furthermore, a double point mutation,
C fi A and G fi T, introduced a compensatory T in
the other part of the stem (Fig. 6A), thus regenerating
the stem-loop structure in strain IQB857 and drasti-
cally reducing the expression of araL¢-¢lacZ (Fig. 6B).
In addition, as described above, a single-point muta-
tion C fi G was designed in the same position and the
effect was analyzed in strain IQB855 (Fig. 6B). How-
ever, no significant effect was detected in the expres-
sion of the translational fusion, suggesting that the
increase of 3 kcalÆmol)1 is insufficient for disrupting
this particular RNA secondary structure. Similarly, no
translation was measured in strain IQB853 carrying a
double point mutation, C fi G and G fi C, which
introduced a compensatory C in the other part of the
stem (Fig. 6). These results clearly show that the hair-
pin structure play an active role in the control of araL
expression. The regulatory mechanism operating in this
situation is most probably sequestration of the ribo-
some binding by the mRNA secondary structure, con-
sequently preventing translation, although the
possibility of premature transcription termination by
early RNA polymerase release cannot be excluded.
Translational attenuation by mRNA secondary struc-
ture comprising the initiation region is present in many
systems of Bacteria, including B. subtilis [32]. As a
result the nature of the NagD family members display-
ing low specificity and catalytic activities and lacking
A
B
Fig. 5. Site-directed mutagenesis at the 5¢-end of the araL gene
and overproduction of recombinant AraL-His6. (A) The secondary
structure of the araL mRNA in pLG12 (left) and pLG13 (right),
which bears a single nucleotide change. An arrowhead highlights
the mutated nucleotide located at the beginning of the araL coding
region. The ribosome-binding site, rbs, and the initiation codon
(ATG) are boxed. The position relative to the transcription start site
is indicated. The free energy of the two secondary structures, cal-
culated by DNASIS, version 3.7 (Hitachi Software Engineering Co.
Ltd, Tokyo, Japan), is shown. (B) Overproduction of recombinant
AraL-His6. Analysis of the soluble (S) and insoluble (P) protein frac-
tion (20 lg of total protein) of induced cultures of E. coli Bl21(DE3)
pLysS harboring pLG12 (AraL-His6) and pLG113 (AraL-His6 G fi A).
The proteins were separated by SDS ⁄ PAGE 12.5% gels and
stained with Coomassie blue. A white arrowhead indicates AraL-
His6. The sizes (kDa) of the broad-range molecular mass markers
(Bio-Rad Laboratories) are indicated.
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clear boundaries defining physiological substrates, reg-
ulation at the genetic level was anticipated [13]. In the
present study, we show for the first time that a genetic
regulatory mechanism controls the expression ⁄produc-
tion of a member of the NagD family, AraL.
The AraL enzyme encoded by the arabinose meta-
bolic operon araABDLMNPQ-abfA was previously
shown to be dispensable for arabinose utilization in a
strain bearing a large deletion comprising all genes
downstream from araD. However, this strain displayed
some growth defects [12]. To confirm this hypothesis,
an in-frame deletion mutation in the araL gene was
generated by allelic replacement, aiming to minimize
the polar effect on the genes of the araABDLMNPQ-
abfA operon located downstream of araL (Fig. 1). The
physiological effect of this knockout mutation in
B. subtilis (strain IQB832 DaraL; Table 1) was assessed
by determining the growth kinetics parameters using
glucose and arabinose as the sole carbon and energy
source. In the presence of glucose and arabinose, the
doubling time of the mutant (49.7 ± 0.3 and
52.4 ± 0.1 min, respectively) is comparable to that of
the wild-type strain (46.6 ± 0.4 and 52.2 ± 0.5 min,
respectively), indicating both the stability of the strain
bearing the in-frame deletion and the fact that the
AraL enzyme is not involved in l-arabinose utilization.
The substrate specificity of AraL points to a biological
function within the context of carbohydrate metabo-
lism. The location of the araL gene in the arabinose
metabolic operon, together with the observation that
AraL is active towards d-xylulose 5-phosphate, a
metabolite resulting from l-arabinose catabolism, sug-
gests that AraL, similar to other HAD phosphatase
members, may help the cell to get rid of phosphory-
lated metabolites that could accumulate accidentally
via stalled pathways. The arabinose operon is under
the negative control of the transcription factor AraR
and, in an araR-null mutant, the expression of the
operon is constitutive. In a previous study [14], the
addition of arabinose to an early-exponentially grow-
ing culture of this mutant resulted in immediate cessa-
tion of growth. It was speculated that this effect could
be the result of an increased intracellular level of arabi-
nose, which would consequently cause an increase in
the concentration of the metabolic sugar phosphate
intermediates that are toxic to the cell [14]. Thus, we
may hypothesize that AraL possibly plays a role in the
dephosphorylation of substrates related to l-arabinose
metabolism, namely l-ribulose phosphate and ⁄or
d-xylulose phosphate. In addition, because of its
A B
Fig. 6. Regulation of araL in B. subtilis. (A) Site-directed mutagenesis at the 5¢-end of the araL gene. The secondary structure of the ara-
ABDLMNPQ-abfA mRNA at the 5¢-end of the araL coding region is depicted. An arrow highlights the mutated nucleotide (circled) located at
the beginning of the araL coding region. The ribosome-binding site, rbs, is boxed. (B) Expression from the wild-type and mutant araL¢-¢lacZ
translational fusions. The B. subtilis strains IQB847 (Para-araL¢-lacZ), IQB849 [Para-araL¢ (C fi A)-¢lacZ], IQB857 [Para-araL¢ (C fi A and
G fi T)-¢lacZ], IQB855 [Para-araL¢ (C fi G)-¢lacZ] and IQB853 [Para-araL¢ (C fi G and G fi C)-¢lacZ] were grown on C minimal medium supple-
mented with casein hydrolysate in the absence (non-induced) or presence (induced) of arabinose. Samples were analyzed 2 h after induction.
The levels of accumulated b-galactosidase activity represent the mean ± SD of three independent experiments, each performed in triplicate.
A schematic representation of the translation fusion is depicted and the point mutations in the stem-loop structure are indicated by an aster-
isk. The free energy of the wild-type (WT) and mutated secondary structures, calculated by DNASIS, version 3.7 (Hitachi Software Engineering
Co. Ltd), are shown.
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capacity to catabolize other related secondary metabo-
lites, this enzyme needs to be regulated. Moreover, the
araL gene is under the control of the operon promoter,
which is a very strong promoter, and basal expression
in the absence of inducer is always present [14]. The
second level of regulation within the operon that oper-
ates in araL expression will act to drastically reduce
the production of AraL.
Experimental procedures
Substrates
pNPP was purchased from Apollo Scientific Ltd (Stockport,
UK) and d-xylulose 5-phosphate, glucose 6-phosphate, fruc-
tose 6-phosphate, fructose 1,6-bisphosphate, ribose 5-phos-
phate, d-arabinose 5-phosphate, galactose 1-phosphate,
glycerol 3-phosphate, pyridoxal 5-phosphate, thiamine
monophosphate, ATP, ADP and AMP were obtained from
Sigma-Aldrich (St Louis, MO, USA).
Bacterial strains and growth conditions
E. coli strains XL1Blue (Stratagene, La Jolla, CA, USA) or
DH5a (Gibco-BRL, Carlsbad, CA, USA) were used for
molecular cloning work and E. coli BL21 (DE3)(pLysS)
was used for the overproduction of AraL (Table 1). E. coli
strains were grown in LB medium [33] or in auto-induction
medium [20]. Ampicillin (100 lgÆmL)1), chloramphenicol
(25 lgÆmL)1), kanamycin (30 lgÆmL)1), tetracycline
(12 lgÆmL)1) and IPTG (1 mm) were added as appropriate.
B. subtilis was grown in liquid LB medium, LB medium
solidified with 1.6% (w ⁄ v) agar, with chloramphenicol
(5 lgÆmL)1), erythromycin (1 lgÆmL)1) and X-Gal
(50 lgÆmL)1) being added as appropriate. Growth kinetics
parameters of the wild-type and mutant B. subtilis strains
were determined in CSK liquid minimal medium [34], as
described previously [27]. Cultures were grown on an Aqua-
tron Waterbath rotary shaker (Infors HT, Bottmingen,
Switzerland), at 37 C (unless stated otherwise) and
180 r.p.m., and A600 was measured in an Ultrospec 2100
pro UV ⁄Visible Spectrophotometer (GE Healthcare Life
Sciences, Uppsala, Sweden).
DNA manipulation and sequencing
DNA manipulations were carried out as described previ-
ously by Sambrook et al. [35]. Restriction enzymes were
purchased from MBI Fermentas (Vilnius, Lithuania) or
New England Biolabs (Hitchin, UK) and used in accor-
dance with the manufacturer’s instructions. DNA ligations
were performed using T4 DNA Ligase (MBI Fermentas).
DNA was eluted from agarose gels with GFX Gel Band
Purification kit (GE Healthcare Life Sciences) and plasmids
were purified using the Qiagen Plasmid Midi kit (Qiagen,
Hilden, Germany) or QIAprep Spin Miniprep kit (Qia-
gen). DNA sequencing was performed with ABI PRIS Big-
Dye Terminator Ready Reaction Cycle Sequencing kit
(Applied Biosystems, Carlsbad, CA, USA). PCR amplifica-
tions were conducted using high-fidelity Phusion DNA
polymerase from Finnzymes (Espoo, Finland).
Plasmid constructions
Plasmids pLG5, pLG11 and pLG12 are pET30a derivatives
(Table 1), which harbor different versions of araL bearing
a C-terminal His6-tag, under the control of a T7 inducible
promoter. The coding sequence of araL was amplified by
PCR using chromosomal DNA of the wild-type strain
B. subtilis 168T+ as template and different sets of primers.
To construct pLG5, oligonucleotides ARA439 and
ARA440 (Table 1) were used and introduced unique NdeI
and XhoI restriction sites at the 5¢ and 3¢ end, respectively,
and the resulting PCR product was inserted into pET30a
digested with the same restriction enzymes. Using the same
procedure, primers ARA457 and ARA440 (Table 1) gener-
ated pLG11. ARA457 introduced a mutation, which substi-
tutes Val at position 8 to Met (Fig. 1). Plasmid pLG12 was
constructed with primers ARA456 and ARA440. Primer
ARA456 inserted an NdeI restriction site in the araL
sequence at the second putative start codon (Fig. 1).
Site-directed mutagenesis
Vector pLG12 was used as template for site-directed muta-
genesis experiments using the mutagenic oligonucleotides
set ARA486 and ARA487 (Table 1). This pair of primers
generated a G fi A substitution at the 5¢-end of the araL
coding region (Fig. 1). This substitution gave rise to a
mutation in the residue at position 12 (Gly to Asp) in the
resulting plasmid pLG13. PCR was carried out using
1 · Phusion GC Buffer (Finnzymes), 0.2 lm primers,
200 lm dNTPs, 3% dimethylsulfoxide, 0.4 ngÆlL)1 pLG12
DNA and 0.02 UÆlL)1 of Phusion DNA polymerase in a
total volume of 50 lL. The PCR product was digested with
10 U of DpnI, at 37 C, overnight. The mutation was
confirmed by sequencing.
Overproduction and purification of recombinant
AraL proteins in E. coli
Small-scale growth of E. coli BL21(DE3) pLysS cells har-
boring pLG5, pLG11, pLG12 and pLG13 was performed
to assess the overproduction and solubility of the recombi-
nant proteins. Cells were grown at 37 C, at 180 r.p.m. and
1 mm IPTG was added when A600 of 0.6 was reached. Cul-
tures were then grown for an additional 3 h at 37 C and
180 r.p.m. Whenever protein solubility was not observed,
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an auto-induction regime for the overproduction of AraL
recombinant proteins was used [20]. To prepare the cell-free
extracts, the cells were resuspended in lysis buffer (20 mm
sodium phosphate buffer, pH 7.4, 62.5 mm NaCl, 10 mm
imidazole, glycerol 10%) and disrupted in the presence of
lysozyme (1 mgÆmL)1) by three cycles of freezing in liquid
nitrogen and thawing for 5 min at 37 C, followed by incu-
bation with benzonase nuclease (Novagen, Darmstadt,
Germany). After 15 min of centrifugation at 16 000 g and
4 C, the soluble and insoluble fractions of the crude
extract were obtained.
For overproduction and purification of recombinant
AraL-His6, E. coli BL21(DE3) pLysS cells harboring
pLG11 were grown in 100 mL of auto-induction medium
[20]. Cells were harvested by centrifugation at 6000 g and
4 C for 10 min. All subsequent steps were carried out at
4 C. The harvested cells were resuspended in Start Buffer
(TrisHCl 100 mm buffer, pH 7.4, 62.5 mm NaCl, 10 mm
imidazole, glycerol 10%) and lysed by passing three times
through a French pressure cell. The lysate was centrifuged
for 1 h at 13 500 g and the proteins from the supernatant
were loaded onto a 1 mL Histrap Ni2+-nitrilotriacetic acid
affinity column (GE Healthcare Life Sciences). The bound
proteins were eluted with a discontinuous imidazole gradi-
ent and those fractions containing AraL that were more
than 95% pure were dialysed overnight against storage buf-
fer (TrisHCl 100 mm buffer, pH 7.4, 100 mm NaCl, glyc-
erol 10%) and then frozen in liquid nitrogen and kept at
)80 C until further use.
Protein analysis
Analysis of production, homogeneity and the molecular
mass of the enzyme were determined by SDS ⁄PAGE using
broad-range molecular weight markers (Bio-Rad Laborato-
ries, Hercules, CA, USA) as standards. The degree of puri-
fication was determined by densitometric analysis of
Coomassie blue-stained SDS ⁄PAGE gels. The protein con-
tent was determined by using Bradford reagent (Bio-Rad
Laboratories) with BSA as standard.
Enzyme assays
Phosphatase activity
Phosphatase activity assays were performed using the gen-
eral substrate pNPP. The reaction mixture comprising
100 mm Tris–HCl buffer, pH 7, containing 15 mm MgCl2
and appropriately diluted enzyme (20 lg) was incubated at
37 C for 5 min. Addition of 20 mm pNPP started the reac-
tion and the mixture was incubated for an additional 1 h.
The reaction was stopped by adding 1 mL of 0.2 m NaOH,
the tubes were centrifuged at 16 000 g for 1 min and 1 mL
of the supernatant was recovered for measurement of A405.
A calibration curve for phosphatase activity assays using
pNPP as a substrate was made using various concentrations
(mgÆmL)1) of p-nitrophenol, within the measuring range of
the method [36]. Negative controls were made using 20 lg of
BSA, and blanks had no protein added. Enzymatic activity
was also determined in the presence of 15 mm EDTA, using
the same conditions: 1 U of AraL hydrolyses, 1 lmol of sub-
strate per min. Both optimum temperature and pH for enzy-
matic activity of AraL-His6 were determined as described
above. The effect of temperature was tested in 100 mm Tris–
HCl buffer, pH 7, containing 15 mm MgCl2, at temperatures
in the range 25–70 C. The effect of pH on the activity was
assayed at 65 C in a series of Britton–Robinson buffers
(0.1 m boric acid, 0.1 m acetic acid and 0.1 m phosphoric
acid, pH 3–6, and Tris–HCl buffers, pH 7.0–9.0).
Continuous activity assays
All continuous assays were carried out at 37 C in 100 mm
Tris–HCl buffer, pH 7, containing 15 mm MgCl2, unless
stated otherwise. Glucose production from glucose 6-phos-
phate was monitored by measurement of the glucose dehy-
drogenase catalysed reduction of NADP. The initial
velocity of glucose formation by dephosphorylation of glu-
cose 6-phosphate in reaction solutions initially containing
20 lg of AraL, 0.7 U of glucose 6-phosphate dehydroge-
nase, 0.2 mm NADP, 1–15 mm a-glucose 6-phosphate and
15 mm MgCl2 in 0.5 mL of 100 mm Tris–HCl (pH 7.5,
37 C) was determined by monitoring the increase in A340.
Discontinuous assays
Initial phosphate hydrolysis for all substrates used in sub-
strate screening was assessed to detect total phosphate
release using the Malachite Green Phosphate Detection Kit
(R&D Systems, Minneapolis, MN, USA) in accordance
with the manufacturer’s instructions. The 150 lL assay
mixture comprising 100 mm Tris–HCl buffer (pH 7), con-
taining 15 mm MgCl2, was incubated for 1 h at 37 C.
Background phosphate levels were monitored in parallel
using a control reaction without the AraL enzyme. A620
was measured. Steady-state kinetics was carried out using
20 lg of AraL with varying concentrations of substrates.
Kinetic parameters were determined using the enzyme
kinetics software graphpad prism, version 5.03 (GraphPad
Software Inc., San Diego, CA, USA).
In-frame deletion of araL in B. subtilis
To create B. subtilis mutant strains with an in-frame dele-
tion of araL, plasmid pLG10 was constructed using pMAD
(Table 1). Regions immediately upstream and downstream
of araL were amplified by two independent PCR experi-
ments, from chromosomal DNA of B. subtilis 168T+, using
primers ARA444 and ARA458 (PCR1) and ARA459 and
ARA460 (PCR2). The products were joined by overlapping
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PCR, with primers ARA444 and ARA460 (Table 1), and
the resulting 1262 bp fragment was digested with BamHI
and EcoRI and cloned into pMAD BamHI-EcoRI, yielding
pLG10. This plasmid harboring an in-frame deletion of
araL was used for integration and generation of a clean
deletion in the B. subtilis chromosome, as described previ-
ously by Arnaud et al. [37]. The in-frame deletion was then
confirmed by DNA sequencing and the resulting strain was
named IQB832. Transformation of B. subtilis was per-
formed as described previously by Anagnostopoulos &
Spizizen [38].
Construction of an-inframe araL¢-¢lacZ fusion and
integration at an ectopic site
To construct plamid pLG25, the arabinose operon pro-
moter region ()81 to +129, relative to the transcriptional
start site) was amplified from chromosomal DNA of the
B. subtilis wild-type strain 168T+ using oligonucleotides
ARA28 and ARA451 (Table 1). The primers introduced
unique EcoRI and HindIII restriction sites and the result-
ing fragment was sub-cloned into the same sites of the
cloning vector pLG1 (L. M. Godinho & I. de Sa´ Nogueira,
unpublished results). Sequentially, the 5¢-end of the araL
coding region comprising the rbs (position +3910 to
+4020, relative to the transcriptional start site of the
operon) was amplified from the wild-type strain with oligo-
nucleotides ARA253 and ARA477 (Table 1), which carry
unique XbaI and BamHI restriction sites and allow the
insertion of this fragment between the NheI and BamHI
sites of pLG1. In the resulting plasmid, a deletion of the
araA rbs and araA start site present in the arabinose pro-
moter region (Para) was performed by overlapping PCR
using two set of primers: ARA358 and ARA514, and
ARA515 and ARA516 (Table 1). The resulting fragment
of 216 bp, comprising the arabinose promoter region
(Para) from )81 to +80 fused to the 5¢-end of the araL
coding region from +3952 to +4007, was inserted into
the vector pAC5 (Table 1), yielding pLG25. Plasmid
pLG25 carries a translational fusion between codon 10 of
araL and codon 7 of E. coli lacZ. pLG25 was used as
template for site-directed mutagenesis experiments using
the mutagenic oligonucleotides set ARA509 and ARA510
(Table 1), as described above. This pair of primers gener-
ated a C fi A substitution at the 5¢-end of the araL cod-
ing region (Figs 1 and 6A). The substitution gave rise to a
mutation in the residue at position 9 (Thr to Lys) in the
resulting plasmid pLG26. pLG26 was then used as tem-
plate for site-directed mutagenesis using primers ARA549
and ARA550, which allowed a C fi G substitution (Thr
to Arg) in position 9, thus giving rise to pLG28. The oli-
gonucleotide set ARA551 and ARA552 introduced a dou-
ble point mutation at the 5¢-end of the araL coding
sequence. Using pLG26 as template, the set of primers
caused T fi C (Arg to Pro) and C fi G (Thr to Arg)
mutations in the second and ninth positions, respectively,
yielding pLG27. Plasmid pLG29 was obtained using site-
directed mutagenesis from pLG26, using the oligonucleo-
tide pair ARA553 and ARA554, giving rise to a G fi T
substitution (Arg to Leu) in position 2. The constructions
were confirmed by DNA sequencing.
DNA from plasmids pLG25, pLG26, pLG27, pLG28
and pLG29, carrying the different araL¢-¢lacZ translational
fusions, was used to transform B. subtilis strains (Table 1)
and the fusions ectopically integrated into the chromosome
via double recombination with the amyE gene back and
front sequences. This event led to the disruption of the
amyE locus and was confirmed as described previously [14].
b-Galactosidase activity assays
Strains of B. subtilis harboring the transcriptional lacZ
fusions were grown were in liquid C minimal medium [14]
supplemented with casein hydrolysate 1% (w ⁄ v), and arabi-
nose was added to the cultures, when necessary, at a final
concentration of 0.4% (w ⁄ v), as described previously [14].
Samples of cell culture (100 lL) were collected 2 h (i.e.
exponential growth phase) after induction and the level of
accumulated b-galactosidase activity was determined by
incubation for 30 min at 28 C with the chromogenic sub-
strate, as described previously [14].
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